COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,944 Articles (22,604 medRxiv, 8,340 bioRxiv)

Most recent first Previous |  Page 2171: Articles 21701-21710  | Next

SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro
Hsu, A. C.-Y., Wang, G., Reid, A. T., Veerati, P. C., Pathinayake, P. S., Daly, K., Mayall, J. R., Hansbro, P. M., Horvat, J. C., Wang, F., Wark, P. A.
10.1101/2020.09.30.317818 — Posted: 2020-10-01 Discussion: Onsite | Offsite
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
Jones, B. E., Brown-Augsburger, P. L., Corbett, K. S., Westerndorf, K., Davies, J., Cujec, T. P., Wiethoff, C. M., Blackbourne, J. L., Heinz, B. A., Foster, D., Higgs, R. E., Balasubramaniam, D., Wang, L., Bidshahri, R., Kraft, L., Hwang, Y., Zentelis, S., Jepson, K. R., Goya, R., Smith, M. A., Collins, D. W., Hinshaw, S. J., Tycho, S. A., Pellacani, D., Xiang, P., Muthuraman, K., Sobhanifar, S., Piper, M. H., Triana, F. J., Hendle, J., Pustilnik, A., Adams, A. C., Berens, S. J., Baric, R. S., Martinez, D. R., Cross, R. W., Geisbert, T. W., Borisevich, V., Abiona, O., Belli, H. M., de Vries, M., Mohamed, A., Dittmann, M., Samanovic, M., Mulligan, M. J., Goldsmith, J. A., Hsieh, C.-L., Johnson, N. V., Wrapp, D., McLellan, J. S., Barnhart, B. C., Graham, B. S., Mascola, J. R., Hansen, C. L., Falconer, E.
10.1101/2020.09.30.318972 — Posted: 2020-10-01
SARS-CoV-2 antibody testing in a UK population: detectable IgG for up to 20 weeks post infection.
Robertson, L. J., Moore, J. S., Blighe, K., Ng, K. Y., Quinn, N., Jennings, F., Warnock, G., Sharpe, P., Clarke, M., Maguire, K., Rainey, S., Price, R., Burns, W., Kowalczyk, A., Awuah, A., McNamee, S., Wallace, G., Sager, S., Chao Shern, C., Nesbit, M. A., McLaughlin, J., Moore, T.
10.1101/2020.09.29.20201509 — Posted: 2020-10-01
SARS-CoV-2 antibody responses in patients with aggressive haematological malignancies
O'Nions, J., Muir, L., Zheng, J., Rees-Spear, C., Rosa, A., Earl, C., Cherepanov, P., Gupta, R., Khwaja, A., Jolly, C., McCoy, L. E.
10.1101/2020.09.29.20202846 — Posted: 2020-10-01
Missed opportunities of flu vaccination in Italian target categories: insights from the online EPICOVID 19 survey
Giacomelli, A., Galli, M., Maggi, S., Pagani, G., Antonelli Incalzi, R., Pedone, C., Di Bari, M., Noale, M., Trevisan, C., Bianchi, F., Tavio, M., Andreoni, M., Mastroianni, C., Sojic, A., Prinelli, F., Adorni, F.
10.1101/2020.09.30.20204560 — Posted: 2020-09-30
Conservative Management of Acute Appendicitis In The Era Of COVID 19: A Multicenter prospective observational study at The United Arab Emirates
AL Hashmi, F. Y., Al Zuabi, A., Hachim, I. Y., Mannaerts, G. H. H., Bekdache, O.
10.1101/2020.09.30.20204503 — Posted: 2020-09-30
Functional Landscape of SARS-CoV-2 Cellular Restriction
Martin-Sancho, L., Lewinski, M. K., Pache, L., Stoneham, C., YIN, X., Pratt, D., Churas, C., Rosenthal, S. B., Liu, S., De Jesus, P. D., O'Neill, A. M., Gounder, A. P., Nguyen, C., Pu, Y., Oom, A. L., Miorin, L., Rodriguez-Frandsen, A., Urbanowski, M., Shaw, M. L., Chang, M. W., Benner, C., Frieman, M., Garcia-Sastre, A., Ideker, T., Hultquist, J. F., Guatelli, J., Chanda, S.
10.1101/2020.09.29.319566 — Posted: 2020-09-30 Discussion: Offsite
Host range projection of SARS-CoV-2: South Asia perspective
Ahmed, R., Hasan, R., Siddiki, A. Z., Islam, M. S.
10.1101/2020.09.30.320242 — Posted: 2020-09-30
Computational identification of human biological processes and protein sequence motifs putatively targeted by SARS-CoV-2 proteins using protein-protein interaction networks
Nadeau, R., Shahryari Fard, S., Scheer, A., Hashimoto-Roth, E., Nygard, D., Abramchuk, I., Chung, Y.-E., Bennett, S. A. L., Lavallee-Adam, M.
10.1101/2020.09.29.318931 — Posted: 2020-09-30
The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells.
Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., Kugathasan, R., Penn, R., Brown, J. C., Sanchez-David, R. Y., Braga, L., Williamson, M. K., Hassard, J. A., Staller, E., Hanley, B., Osborn, M., Giacca, M., Davidson, A. D., Matthews, D. A., Barclay, W. S.
10.1101/2020.09.30.318311 — Posted: 2020-09-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).